Sydney E. Salmon mainly focuses on Internal medicine, Chemotherapy, Oncology, Multiple myeloma and Vincristine. His Internal medicine research incorporates themes from Gastroenterology, Myeloma cast nephropathy and Surgery. His work deals with themes such as Clinical research and Immunology, which intersect with Chemotherapy.
His studies deal with areas such as Putrescine, Predictive value and Body surface area as well as Oncology. His Multiple myeloma research is multidisciplinary, incorporating elements of Cancer research, Stage, Bone marrow, Pathology and Creatinine. The study incorporates disciplines such as Melphalan and Doxorubicin in addition to Vincristine.
The scientist’s investigation covers issues in Internal medicine, Oncology, Pharmacology, Chemotherapy and Cancer research. His work in Internal medicine tackles topics such as Gastroenterology which are related to areas like Adenocarcinoma. He interconnects Clinical trial, Radiation therapy, Adjuvant therapy and Carcinoma in the investigation of issues within Oncology.
His Pharmacology research includes elements of Vinblastine, In vitro, Cytotoxicity and Doxorubicin. His Chemotherapy study is associated with Surgery. His Multiple myeloma research integrates issues from Bone marrow, Pathology and Prednisone.
His primary areas of study are Biochemistry, Pharmacology, Internal medicine, Peptide and Chemotherapy. His Pharmacology research incorporates elements of Drug resistance, Immunology, Fetal bovine serum and Cytotoxicity. Sydney E. Salmon undertakes multidisciplinary studies into Internal medicine and Verapamil in his work.
His Peptide study integrates concerns from other disciplines, such as Combinatorial chemistry, Anticancer drug and Drug discovery. His Chemotherapy study is related to the wider topic of Surgery. The Regimen study combines topics in areas such as Cyclophosphamide and Oncology.
His primary areas of investigation include Combinatorial chemistry, Cleavable linker, Pharmacology, Immunology and Cancer. The concepts of his Combinatorial chemistry study are interwoven with issues in Cleavage and Peptide, Solid-phase synthesis, Peptide synthesis. Chemotherapy is closely connected to Radiation therapy in his research, which is encompassed under the umbrella topic of Pharmacology.
His research integrates issues of Cisplatin, Blood proteins, IC50, Albumin and In vivo in his study of Immunology. He has included themes like Carboplatin, Survival analysis, Nephrotoxicity and Nedaplatin in his Cancer study. He is investigating Oncology and Internal medicine as part of his examination of Chemoradiotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
Brian G. M. Durie;Sydney E. Salmon.
Primary bioassay of human tumor stem cells
Sydney E. Salmon;Anne W. Hamburger.
A new type of synthetic peptide library for identifying ligand-binding activity
Kit S. Lam;Sydney E. Salmon;Evan M. Hersh;Victor J. Hruby.
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
Robert C. Flanigan;Sydney E. Salmon;Brent A. Blumenstein;Scott I. Bearman.
The New England Journal of Medicine (2001)
Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs
Sydney E. Salmon;Anne W. Hamburger;Barbara Soehnlen;Brian G. M. Durie.
The New England Journal of Medicine (1978)
Evidence for the secretion of an osteoclast stimulating factor in myeloma.
Gregory R. Mundy;Lawrence G. Raisz;Robert A. Cooper;Geraldine P. Schechter.
The New England Journal of Medicine (1974)
Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma.
Bart Barlogie;Sundar Jagannath;David H. Vesole;Sally Naucke.
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
Kit Sang Lam;Sydney E. Salmon;Victor J. Hruby;Evan M. Hersh.
Primary Bioassay of Human Myeloma Stem Cells
Anne Hamburger;Sydney E. Salmon.
Journal of Clinical Investigation (1977)
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.
W. S. Dalton;T. M. Grogan;P. S. Meltzer;R. J. Scheper.
Journal of Clinical Oncology (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: